Video

Q&A With Scott Solomon From Brigham & Women's Hospital: New Study Shows Improvement In Rehospitalization In Heart Failure Patients

Author(s):

Rehospitalization is becoming a growing concern in the health care field with health systems facing financial consequences if they do not reach certain benchmarks. A recent study of an approved medication showed benefits in this area that could help patients and providers alike.

Rehospitalization is becoming a growing concern in the health care field with health systems facing financial consequences if they do not reach certain benchmarks. A recent study of an approved medication showed benefits in this area that could help patients and providers alike.

Scott D. Solomon, MD, from Brigham & Women's Hospital discussed the new results of the Paradigm study looking at hospitalization and the impact of Valsartan/sacubitril and what it can mean for future care of patients with this condition during the American Heart Association's annual meeting in Orlando.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.